Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Inflammatory Bowel Diseases

Free Subscription Articles published in J Clin Gastroenterol Retrieve available abstracts of 75 articles: HTML format

Single Articles

May 2026
1. CHOCHINOV S, Dolovich C, Ly G, Oketola A, et al
   A Population-Based Assessment of Physical Activity and Exercise in Persons With IBD.
   J Clin Gastroenterol. 2026;60:432-441.
   PubMed     Abstract available
   
   
   April 2026
2. KHALIL C, Mehra M, Yang Y, Choi SY, et al
   Development and Validation of Crohn's Perianal Fistula Educational Videos and Website for Increasing Patient Knowledge and Engagement.
   J Clin Gastroenterol. 2026;60:363-371.
   PubMed     Abstract available
   
   
   March 2026
3. CHOU C, Sanchirico M, Mukherjee RS, Hudesman D, et al
   Defining Moderate Disease Activity and Severity in Crohn's Disease and Ulcerative Colitis.
   J Clin Gastroenterol. 2026 Mar 24. doi: 10.1097/MCG.0000000000002349.
   PubMed     Abstract available
   
   
   
4. DOU Q, Yao Y, Liu L
   Comments on "Increased Prevalence of Pulmonary Diseases in Patients With Inflammatory Bowel Disease: A Retrospective Multicenter Study".
   J Clin Gastroenterol. 2026 Mar 23. doi: 10.1097/MCG.0000000000002363.
   PubMed    
   
   
   
5. ELDESOUKI MH, Elfert K, Alkasabrah O, Elsharkawy MM, et al
   Comparative Effectiveness of Upadacitinib Versus Ustekinumab in Ulcerative Colitis Patients With Prior Tumor Necrosis Factor Inhibitor Exposure: A matched Cohort Study.
   J Clin Gastroenterol. 2026 Mar 16. doi: 10.1097/MCG.0000000000002354.
   PubMed     Abstract available
   
   
   
6. TARIQ R, Sterling RK, Afzali A, Sanyal AJ, et al
   From Gut to Metabolism: Exploring the Intersection of Inflammatory Bowel Disease and Systemic Metabolic Dysfunction.
   J Clin Gastroenterol. 2026 Mar 11. doi: 10.1097/MCG.0000000000002359.
   PubMed     Abstract available
   
   
   
7. NGUYEN B, Quon S, Williams AJ, Leung Y, et al
   Safety of Vedolizumab in Pregnancy: An Updated Systematic Review and Comprehensive Meta-analysis.
   J Clin Gastroenterol. 2026;60:225-231.
   PubMed     Abstract available
   
   
   February 2026
8. FERRANTE M, Christensen B, Bressler B, Brett NR, et al
   Real-World Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease: Results From the EVOLVE Expansion Chart Review Study.
   J Clin Gastroenterol. 2026 Feb 24. doi: 10.1097/MCG.0000000000002350.
   PubMed     Abstract available
   
   
   
9. FIERENS L, Liefferinckx C, Sabino J, De Dycker E, et al
   Development of an Evidence-based Quality Indicator Set for Patients With Inflammatory Bowel Disease in Belgium.
   J Clin Gastroenterol. 2026 Feb 23. doi: 10.1097/MCG.0000000000002145.
   PubMed     Abstract available
   
   
   
10. HOLMGREN J, Akhlaghi A, Drake I, Grip O, et al
    Risk of Infection Before and After Thiopurine Therapy in Inflammatory Bowel Disease: A Population-Based Study.
    J Clin Gastroenterol. 2026 Feb 13. doi: 10.1097/MCG.0000000000002351.
    PubMed     Abstract available
    
    
    
11. LIU L, Yao Y, Li S
    Comments on "Suicide Attempts, Schizophrenia, and Depression Among Inflammatory Bowel Disease Patients"??????: Data From a Large Database.
    J Clin Gastroenterol. 2026 Feb 9. doi: 10.1097/MCG.0000000000002345.
    PubMed    
    
    
    January 2026
12. SUN H, Chen H, Zhou Z, Zhou J, et al
    The Impact of Sarcopenia on the Efficacy of Ustekinumab in Crohn's Disease.
    J Clin Gastroenterol. 2026 Jan 26. doi: 10.1097/MCG.0000000000002331.
    PubMed     Abstract available
    
    
    
13. BERNSTEIN CN, Nugent Z, Panaccione R, Marshall DA, et al
    Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine.
    J Clin Gastroenterol. 2026 Jan 23. doi: 10.1097/MCG.0000000000002329.
    PubMed     Abstract available
    
    
    
14. AILAWADI S, Sethi S, Mahmood A, Harper E, et al
    Extraintestinal Cutaneous Manifestations in Inflammatory Bowel Disease Among Non-White Patients: A Retrospective Multicenter Study.
    J Clin Gastroenterol. 2026 Jan 20. doi: 10.1097/MCG.0000000000002325.
    PubMed     Abstract available
    
    
    
15. BALI AS, El Sheikh WG, Ouni A, Kwon J, et al
    Radiographically-Measured Sarcopenia Predicts Hospitalization in Patients With Crohn's Disease.
    J Clin Gastroenterol. 2026 Jan 20. doi: 10.1097/MCG.0000000000002317.
    PubMed     Abstract available
    
    
    
16. AILAWADI S, Parikh T, Harper E, Perez J, et al
    Increased Prevalence of Pulmonary Diseases in Patients With Inflammatory Bowel Disease: A Retrospective Multicenter Study.
    J Clin Gastroenterol. 2026 Jan 19. doi: 10.1097/MCG.0000000000002327.
    PubMed     Abstract available
    
    
    
17. NJEIM R, Moussa E, Sohail A, Wei C, et al
    Metabolic Comorbidities and Hospital Outcomes in Patients With Inflammatory Bowel Disease: A Nationwide Analysis.
    J Clin Gastroenterol. 2026 Jan 13. doi: 10.1097/MCG.0000000000002333.
    PubMed     Abstract available
    
    
    
18. FELDMAN HT, Tejan J, Victoria R, Rupawala A, et al
    Wearable Technology and Remote Physiological Monitoring in Inflammatory Bowel Disease: A Systematic Review.
    J Clin Gastroenterol. 2026 Jan 5. doi: 10.1097/MCG.0000000000002319.
    PubMed     Abstract available
    
    
    December 2025
19. DUGGAL S, Khattar S, Kattamuri L, Batheja M, et al
    Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Analysis.
    J Clin Gastroenterol. 2025 Dec 31. doi: 10.1097/MCG.0000000000002323.
    PubMed     Abstract available
    
    
    
20. GIRARDI P, Fons AB, Savini C, Maljaars JPW, et al
    Therapy Goals and Well-being in Older Patients With Inflammatory Bowel Disease: Therapy Goals & Wellbeing in Older Adults with IBD.
    J Clin Gastroenterol. 2025 Dec 23. doi: 10.1097/MCG.0000000000002320.
    PubMed     Abstract available
    
    
    
21. DALAL RS, Carlin A, Cabral H, Hardwick GB, et al
    Real-World Comparative Effectiveness of Vedolizumab Versus Upadacitinib for Crohn's Disease Through 52 Weeks.
    J Clin Gastroenterol. 2025 Dec 19. doi: 10.1097/MCG.0000000000002309.
    PubMed     Abstract available
    
    
    
22. RICHTER V, Markovitz N, Krupik Y, Menkes-Caspi N, et al
    Suicide Attempts, Schizophrenia, and Depression Among Inflammatory Bowel Disease Patients: Data From a Large Database.
    J Clin Gastroenterol. 2025 Dec 17. doi: 10.1097/MCG.0000000000002308.
    PubMed     Abstract available
    
    
    November 2025
23. XU X, Li W, Ling T, Lan X, et al
    Combined Endoscopic and Radiologic Approaches for Differentiating Inflammatory and Fibrotic Strictures in Crohn's Disease: A Comprehensive Diagnostic Strategy.
    J Clin Gastroenterol. 2025 Nov 25. doi: 10.1097/MCG.0000000000002294.
    PubMed     Abstract available
    
    
    
24. METSELAAR PI, van der Hoff MJ, van den Broek TJ, Kamstra RJM, et al
    Measuring Fatigue and Heart Rate Variability Using A Wearable Patch in Ulcerative Colitis Patients: A Cross-Sectional Pilot Study.
    J Clin Gastroenterol. 2025 Nov 14. doi: 10.1097/MCG.0000000000002286.
    PubMed     Abstract available
    
    
    
25. KAHAN TF, Delau O, Hong S, Holmer A, et al
    Clostridioides difficile Infection Is Associated With Increased Colectomy Risk in Acute Severe Ulcerative Colitis Treated With Infliximab.
    J Clin Gastroenterol. 2025 Nov 10. doi: 10.1097/MCG.0000000000002276.
    PubMed     Abstract available
    
    
    
26. HEINLE JW, Kazzaz S, Schaefer EW, Liu G, et al
    Opioid Provision After Inpatient Care is Associated With Poor Outcomes in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2025 Nov 5. doi: 10.1097/MCG.0000000000002277.
    PubMed     Abstract available
    
    
    
27. SHENOY S, Debroff J, Lacoste J, Giselbrecht E, et al
    Invisible Burdens: The Influence of Stigma and Social Determinants on Quality of Life in Perianal Fistulizing Crohn's Disease.
    J Clin Gastroenterol. 2025 Nov 3. doi: 10.1097/MCG.0000000000002275.
    PubMed     Abstract available
    
    
    October 2025
28. VASUDEVAN J, Larson D, Damianos J, Shori C, et al
    Fiber Intake in Inflammatory Bowel Disease: Impact of Disease Activity and Predictors of High Fiber Intake.
    J Clin Gastroenterol. 2025 Oct 14. doi: 10.1097/MCG.0000000000002258.
    PubMed     Abstract available
    
    
    September 2025
29. NARDELLI MJ, Cancado GGL, Barros LL, Dotta DD, et al
    Clinical and Prognostic Factors Associated With Inflammatory Bowel Disease in a Highly Admixed Population With Primary Sclerosing Cholangitis.
    J Clin Gastroenterol. 2025 Sep 24. doi: 10.1097/MCG.0000000000002253.
    PubMed     Abstract available
    
    
    
30. TANRIVERDI LH, Aksan F, Aroniadis O, Monzur F, et al
    S1P Receptor Modulators Improve Clinical Outcomes in Ulcerative Colitis: A Stratified Meta-Analysis By Prior Biological Use, Corticosteroid Exposure, and Disease Characteristics.
    J Clin Gastroenterol. 2025 Sep 23. doi: 10.1097/MCG.0000000000002250.
    PubMed     Abstract available
    
    
    
31. CHEN M, Lin Y, Wang B
    When Normal Imaging Says Enough: Rethinking the Role of Patency Capsule in Crohn's Disease.
    J Clin Gastroenterol. 2025 Sep 1. doi: 10.1097/MCG.0000000000002246.
    PubMed    
    
    
    August 2025
32. GRAY JK, Guo B, Baniahmad A, Odat B, et al
    Fecal Short and Branched Chain Acids as Possible Biomarkers for Inflammatory Bowel Disease and UC and CD Subgroups? A Case-Control Study.
    J Clin Gastroenterol. 2025 Aug 18. doi: 10.1097/MCG.0000000000002237.
    PubMed     Abstract available
    
    
    
33. ISHIDA N, Tani S, Takebe T, Takahashi K, et al
    Role of Sepsis Markers as Potential Biomarkers for Inflammatory Bowel Disease: A Prospective Observational Study.
    J Clin Gastroenterol. 2025 Aug 11. doi: 10.1097/MCG.0000000000002236.
    PubMed     Abstract available
    
    
    
34. CUMMINGS F, Smith PJ, Fumery M, Rahmany S, et al
    Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.
    J Clin Gastroenterol. 2025 Aug 6. doi: 10.1097/MCG.0000000000002228.
    PubMed     Abstract available
    
    
    July 2025
35. ODAH T, Palacios P, Sulbaran M, Fluxa D, et al
    Malnutrition and Opioid Use Disorder Are Associated With Higher 30-day Readmission Rates in Patients Admitted for Ulcerative Colitis.
    J Clin Gastroenterol. 2025 Jul 16. doi: 10.1097/MCG.0000000000002189.
    PubMed     Abstract available
    
    
    
36. ZHENG M, DeDecker L, Chen PH, Limketkai BN, et al
    Trends in Substance Use Disorder Among Hospitalized Patients With Inflammatory Bowel Disease: An 11-Year Nationwide Study.
    J Clin Gastroenterol. 2025 Jul 2:10.1097/MCG.0000000000002205.
    PubMed     Abstract available
    
    
    June 2025
37. DAI C, Huang YH
    Impact of Clostridioides difficile Infection on the Outcome of Severe Flare of Ulcerative Colitis.
    J Clin Gastroenterol. 2025 Jun 24. doi: 10.1097/MCG.0000000000002217.
    PubMed    
    
    
    
38. SCHARL M, Christensen B, Bressler B, Brett NR, et al
    Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease By Disease Location: Results from the EVOLVE Expansion Study.
    J Clin Gastroenterol. 2025 Jun 20. doi: 10.1097/MCG.0000000000002186.
    PubMed     Abstract available
    
    
    
39. DA CUNHA T, Hagen R, Vaziri H
    Biological Therapies in Inflammatory Bowel Disease: Predictive Factors of Nonresponse.
    J Clin Gastroenterol. 2025 Jun 20. doi: 10.1097/MCG.0000000000002179.
    PubMed     Abstract available
    
    
    
40. ARIF TB, Ahmad J, Afzal N, Butt MA, et al
    Temporal Trends in Mortality Related to Crohn's Disease in the United States: A 21-year Retrospective Analysis of CDC-WONDER Database.
    J Clin Gastroenterol. 2025 Jun 9. doi: 10.1097/MCG.0000000000002209.
    PubMed     Abstract available
    
    
    May 2025
41. SINGH AK, Shukla S, Acharya R, Birda CL, et al
    Impact of Clostridioides difficile Infection on the Outcome of Severe Flare of Ulcerative Colitis.
    J Clin Gastroenterol. 2025 May 12. doi: 10.1097/MCG.0000000000002196.
    PubMed     Abstract available
    
    
    March 2025
42. LEE SD, Kamp KJ, Jacobs J, Harper J, et al
    Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure.
    J Clin Gastroenterol. 2025 Mar 6. doi: 10.1097/MCG.0000000000002157.
    PubMed     Abstract available
    
    
    February 2025
43. ALI S, Pena AN, Lafazanos YS, Ehrenpreis ED, et al
    What Gastroenterologists Should Know About Microplastics and Nanoplastics.
    J Clin Gastroenterol. 2025;59:105-109.
    PubMed     Abstract available
    
    
    January 2025
44. BERNSTEIN CN, Nugent Z, Panaccione R, Marshall DA, et al
    Symptoms in Persons With Either Active or Inactive Crohn's Disease Are Agnostic to Disease Phenotype: The Magic in Imagine Study.
    J Clin Gastroenterol. 2025 Jan 22. doi: 10.1097/MCG.0000000000002137.
    PubMed     Abstract available
    
    
    
45. LIMKETKAI BN, Li Z, Mullin GE, Parian AM, et al
    Machine Learning-based Prediction of Mortality Among Malnourished Patients Hospitalized With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2025 Jan 20. doi: 10.1097/MCG.0000000000002138.
    PubMed     Abstract available
    
    
    December 2024
46. SHAFFER SR, Chu J, Algarni A, Nugent Z, et al
    Medication Withdrawal With Normal or Near-normal Histology in Ulcerative Colitis is Associated With Clinical Relapse.
    J Clin Gastroenterol. 2024 Dec 23. doi: 10.1097/MCG.0000000000002120.
    PubMed     Abstract available
    
    
    
47. HAN W, Bai B, Wang Y, Hu J, et al
    Infliximab Trough Levels Are Associated With Endoscopic Remission in Small Bowel Crohn's Disease.
    J Clin Gastroenterol. 2024 Dec 2. doi: 10.1097/MCG.0000000000002111.
    PubMed     Abstract available
    
    
    November 2024
48. MOURAD FH, Kariyawasam VC, Leong RW
    Comment on: Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-severe Ulcerative Colitis: A Prospective Multicenter Cohort (MOSAIK) Study.
    J Clin Gastroenterol. 2024 Nov 29. doi: 10.1097/MCG.0000000000002113.
    PubMed    
    
    
    
49. HEGDE Y, Lazarus SK, Farraye FA, Hollnagel F, et al
    High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2024 Nov 6. doi: 10.1097/MCG.0000000000002098.
    PubMed     Abstract available
    
    
    October 2024
50. HYUN HK, Kim JW, Lee J, Jeen YT, et al
    Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis: A Prospective Multicenter Cohort (MOSAIK) Study.
    J Clin Gastroenterol. 2024 Oct 24. doi: 10.1097/MCG.0000000000002087.
    PubMed     Abstract available
    
    
    
51. ISRAEL A, Sharif K, Zada G, Friedenberg A, et al
    Comparative Analysis of Inflammatory Bowel Disease Management: Hospital-based Versus Community-based Care.
    J Clin Gastroenterol. 2024 Oct 22. doi: 10.1097/MCG.0000000000002088.
    PubMed     Abstract available
    
    
    
52. ODAH T, Karime C, Hashash JG, Kinnucan JA, et al
    The Utility of Patency Capsule in Patients With Crohn's Disease.
    J Clin Gastroenterol. 2024 Oct 15. doi: 10.1097/MCG.0000000000002048.
    PubMed     Abstract available
    
    
    September 2024
53. MAHMUD O, Fatimi AS, Mahar MU, Jahangir A, et al
    Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Clin Gastroenterol. 2024;58:753-763.
    PubMed     Abstract available
    
    
    August 2024
54. GHUSN W, Mourad FH, Francis FF, Pasha S, et al
    The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant.
    J Clin Gastroenterol. 2024 Aug 14. doi: 10.1097/MCG.0000000000002049.
    PubMed     Abstract available
    
    
    
55. YARUR AJ, Bressler B, Brett NR, Bassel M, et al
    Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn's Disease: Results From the EVOLVE Study.
    J Clin Gastroenterol. 2024 Aug 2. doi: 10.1097/MCG.0000000000002056.
    PubMed     Abstract available
    
    
    May 2024
56. AHMAD H, Click B, Morris HL, Crawford JM, et al
    Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBD.
    J Clin Gastroenterol. 2024 May 22. doi: 10.1097/MCG.0000000000002015.
    PubMed     Abstract available
    
    
    April 2024
57. KARIME C, Salazar M, Black CN, Caldera F, et al
    In Patients With Inflammatory Bowel Disease, Racial Disparities Exist in Burden of Vaccine-preventable Disease Hospitalizations and Outcomes.
    J Clin Gastroenterol. 2024 Apr 16. doi: 10.1097/MCG.0000000000002005.
    PubMed     Abstract available
    
    
    
58. PETROV JC, Al-Bawardy B, Alzahrani R, Mohamed G, et al
    Rates, Predictors, and Outcomes of Ustekinumab Dose Escalation in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2024 Apr 10. doi: 10.1097/MCG.0000000000002003.
    PubMed     Abstract available
    
    
    March 2024
59. DOLOVICH C, Shafer LA, Graff LA, Vagianos K, et al
    Hormonal Contraceptives Reduce Active Symptomatic Disease but May Increase Intestinal Inflammation in IBD.
    J Clin Gastroenterol. 2024;58:271-276.
    PubMed     Abstract available
    
    
    
60. KHAN N, Trivedi C, Shah Y, Patel M, et al
    Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort.
    J Clin Gastroenterol. 2024;58:277-280.
    PubMed     Abstract available
    
    
    February 2024
61. GODOY-BREWER G, Salem G, Limketkai B, Selaru FM, et al
    Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review.
    J Clin Gastroenterol. 2024;58:183-194.
    PubMed     Abstract available
    
    
    
62. PETROV J, Fine S, Alzahrani R, Mohamed G, et al
    Ustekinumab Drug Levels and Outcomes in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2024 Feb 1. doi: 10.1097/MCG.0000000000001978.
    PubMed     Abstract available
    
    
    January 2024
63. VARMA A, Weinstein J, Seabury J, Rosero S, et al
    The Crohn's Disease-Health Index: Development and Evaluation of a Novel Outcome Measure.
    J Clin Gastroenterol. 2024 Jan 26. doi: 10.1097/MCG.0000000000001976.
    PubMed     Abstract available
    
    
    December 2023
64. KARIME C, Crosby S, Bhat S, Hashash JG, et al
    Rapid Adoption of Pneumococcal 20-Valent Conjugate Vaccination in Adult Patients With Inflammatory Bowel Disease: An Analysis One Year After Availability.
    J Clin Gastroenterol. 2023 Dec 5. doi: 10.1097/MCG.0000000000001954.
    PubMed    
    
    
    November 2023
65. BACHOUR SP, Shah RS, Joseph A, Syed H, et al
    Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
    J Clin Gastroenterol. 2023 Nov 27. doi: 10.1097/MCG.0000000000001943.
    PubMed     Abstract available
    
    
    October 2023
66. NARULA N, Wong ECL, Aruljothy A, Dulai PS, et al
    Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
    J Clin Gastroenterol. 2023;57:913-919.
    PubMed     Abstract available
    
    
    September 2023
67. DOKMAK A, Sweigart B, Orekondy NS, Jangi S, et al
    Efficacy and Safety of Hyperbaric Oxygen Therapy in Fistulizing Crohn's Disease: A Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2023 Sep 11. doi: 10.1097/MCG.0000000000001905.
    PubMed     Abstract available
    
    
    August 2023
68. SMITH ES, Chen J, Pan Y, Mahtani P, et al
    The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.
    J Clin Gastroenterol. 2023 Aug 21. doi: 10.1097/MCG.0000000000001904.
    PubMed     Abstract available
    
    
    
69. DA CUNHA T, Vaziri H
    Interval Colorectal Cancer in Inflammatory Bowel Disease: A Review.
    J Clin Gastroenterol. 2023 Aug 7. doi: 10.1097/MCG.0000000000001901.
    PubMed     Abstract available
    
    
    July 2023
70. BERNSTEIN CN, Dolovich C, Prichodko M, Fisk JD, et al
    Perceived Need for Mental Health Care in a Cohort of Persons With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2023 Jul 21. doi: 10.1097/MCG.0000000000001892.
    PubMed     Abstract available
    
    
    
71. GUBATAN J, Frost S, Levitte S, Keyashian K, et al
    Rates and Predictors of Long-term Clinical Outcomes in Patients With Perianal Crohn's Disease on Biologic Therapy.
    J Clin Gastroenterol. 2023;57:617-623.
    PubMed     Abstract available
    
    
    June 2023
72. DESAI A, Hashash JG, Baker G, Farraye FA, et al
    Effect of Bariatric Surgery on Disease Outcomes in Patients with Inflammatory Bowel Disease: A US-based Propensity Matched Cohort Study.
    J Clin Gastroenterol. 2023 Jun 27. doi: 10.1097/MCG.0000000000001879.
    PubMed     Abstract available
    
    
    
73. KARIME C, Hashash JG, Picco MF, Craver EC, et al
    The Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on the Long-term Disease Course of Patients With Crohn's Disease.
    J Clin Gastroenterol. 2023 Jun 26. doi: 10.1097/MCG.0000000000001881.
    PubMed     Abstract available
    
    
    May 2023
74. BERNSTEIN CN, Regueiro M
    Postoperative Crohn's Disease.
    J Clin Gastroenterol. 2023 May 24. doi: 10.1097/MCG.0000000000001865.
    PubMed     Abstract available
    
    
    
75. DAHIYA DS, Chandan S, Bapaye J, Mohan BP, et al
    Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis.
    J Clin Gastroenterol. 2023 May 23. doi: 10.1097/MCG.0000000000001860.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum